We have recently provided a comprehensive analysis of A-to-I RNA editing events in various cancer types, revealing many clinically relevant RNA editing sites and demonstrating that RNA editing can selectively affect cancer drug sensitivity. Our results unveil mechanistic, prognostic, and therapeutic implications for RNA editing in cancer.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905409 | PMC |
http://dx.doi.org/10.1080/23723556.2015.1117702 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!